High-risk renal cell carcinoma

Clinical trials for High-risk renal cell carcinoma explained in plain language.

Never miss a new study

Get alerted when new High-risk renal cell carcinoma trials appear

Sign up with your email to follow new studies for High-risk renal cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Could an immunotherapy drug keep kidney cancer from returning after surgery?

Disease control Ongoing

This phase 2 trial is testing whether toripalimab, an immunotherapy drug, can prevent high-risk kidney cancer from coming back after surgery to remove the kidney. About 100 participants will receive the drug every three weeks for up to a year. Researchers will track how long they…

Matched conditions: HIGH-RISK RENAL CELL CARCINOMA

Phase 2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:05 UTC

High-risk renal cell carcinoma

Get alerted when new High-risk renal cell carcinoma trials appear

Could an immunotherapy drug keep kidney cancer from returning after surgery?